Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171

PLoS Pathogens

Volumn 7, Issue 9, 2011, Pages

  Striebel, James F ^a   Race, Brent ^a   Meade White, Kimberly D ^a   LaCasse, Rachel ^a   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MOUSE; MOUSE STRAIN; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; SCRAPIE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETICS; HUMAN; METABOLISM; PRION; SPECIES DIFFERENCE; TRANSGENIC MOUSE;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

ANIMALS; HUMANS; MICE; MICE, TRANSGENIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIONS; PROTEIN FOLDING; SCRAPIE; SPECIES SPECIFICITY;

EID: 80053449685     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002275     Document Type: Article

References (82)

1. Sejvar JJ, Schonberger LB, Belay ED, (2008) Transmissible spongiform encephalopathies. J Am Vet Med Assoc 233: 1705-1712.
2. Moore RA, Taubner LM, Priola SA, (2009) Prion protein misfolding and disease. Curr Opin Struct Biol 19: 14-22.
3. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339-1347.
4. Goldmann W, Hunter N, Smith G, Foster J, Hope J, (1994) PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 75 (Pt 5): 989-995.
5. Hunter N, (1997) PrP genetics in sheep and the applications for scrapie and BSE. Trends Microbiol 5: 331-334.
6. Laplanche JL, Chatelain J, Westaway D, Thomas S, Dussaucy M, et al. (1993) PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics 15: 30-37.
7. Benestad SL, Arsac JN, Goldmann W, Noremark M, (2008) Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology. Vet Res 39: 19.
8. Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, et al. (2003) Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec 153: 202-208.
9. Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, et al. (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46: 503-511.
10. Westaway D, Goodman PA, Mirenda CA, McKinley MP, Carlson GA, et al. (1987) Distinct prion proteins in short and long scrapie incubation period mice. Cell 51: 651-662.
11. Moore RC, Hope J, McBride PA, McConnell I, Selfridge J, et al. (1998) Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet 18: 118-125.
12. Bruce ME, McConnell I, Fraser H, Dickinson AG, (1991) The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72 (Pt 3): 595-603.
13. Dickinson AG, Meikle VM, (1969) A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res 13: 213-225.
14. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, et al. (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806-808.
15. Mead S, (2006) Prion disease genetics. Eur J Hum Genet 14: 273-281.
16. Bishop MT, Will RG, Manson JC, (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107: 12005-12010.
17. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, et al. (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 55: 851-859.
18. Lee HS, Brown P, Cervenakova L, Garruto RM, Alpers MP, et al. (2001) Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 183: 192-196.
19. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306: 1793-1796.
20. Palmer MS, Dryden AJ, Hughes JT, Collinge J, (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340-342.
21. Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T, (1998) Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 43: 826-828.
22. Hizume M, Kobayashi A, Teruya K, Ohashi H, Ironside JW, et al. (2009) Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J Biol Chem 284: 3603-3609.
23. Lukic A, Beck J, Joiner S, Fearnley J, Sturman S, et al. (2010) Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease. Arch Neurol 67: 1021-1023.
24. Mead S, Whitfield J, Poulter M, Shah P, Uphill J, et al. (2009) A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med 361: 2056-2065.
25. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300: 640-643.
26. Beck JA, Poulter M, Campbell TA, Adamson G, Uphill JB, et al. (2010) PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 31: E1551-1563.
27. Yang W, Cook J, Rassbach B, Lemus A, DeArmond SJ, et al. (2009) A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci 29: 10072-10080.
28. Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, et al. (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587-1590.
29. Nazor KE, Kuhn F, Seward T, Green M, Zwald D, et al. (2005) Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. Embo J 24: 2472-2480.
30. Barron RM, Thomson V, King D, Shaw J, Melton DW, et al. (2003) Transmission of murine scrapie to P101L transgenic mice. J Gen Virol 84: 3165-3172.
31. Barron RM, Thomson V, Jamieson E, Melton DW, Ironside J, et al. (2001) Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. Embo J 20: 5070-5078.
32. Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, et al. (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. Embo J 18: 6855-6864.
33. Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, et al. (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63: 438-450.
34. Mastrianni JA, Capellari S, Telling GC, Han D, Bosque P, et al. (2001) Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 57: 2198-2205.
35. Dossena S, Imeri L, Mangieri M, Garofoli A, Ferrari L, et al. (2008) Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60: 598-609.
36. Chiesa R, Piccardo P, Ghetti B, Harris DA, (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21: 1339-1351.
37. Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, et al. (2009) De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A 106: 304-309.
38. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, et al. (2010) A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 120: 2590-2599.
39. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, et al. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308: 1435-1439.
40. Meade-White K, Race B, Trifilo M, Bossers A, Favara C, et al. (2007) Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol 81: 4533-4539.
41. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15: 1255-1264.
42. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, et al. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121-127.
43. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, et al. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93: 203-214.
44. Matsunaga Y, Peretz D, Williamson A, Burton D, Mehlhorn I, et al. (2001) Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins 44: 110-118.
45. Meyerett C, Michel B, Pulford B, Spraker TR, Nichols TA, et al. (2008) In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology 382: 267-276.
46. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, et al. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76: 117-129.
47. Saa P, Castilla J, Soto C, (2005) Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol 299: 53-65.
48. Perrier V, Kaneko K, Safar J, Vergara J, Tremblay P, et al. (2002) Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A 99: 13079-13084.
49. Priola SA, Caughey B, Race RE, Chesebro B, (1994) Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68: 4873-4878.
50. Zlotnik I, Rennie JC, (1963) Further observations on the experimental transmission of scrapie from sheep and goats to laboratory mice. J Comp Pathol 73: 150-162.
51. Kimberlin RH, Walker CA, Fraser H, (1989) The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol 70 (Pt 8): 2017-2025.
52. Kimberlin RH, Walker CA, (1978) Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 39: 487-496.
53. Caughey B, Baron GS, Chesebro B, Jeffrey M, (2009) Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78: 177-204.
54. Collinge J, Clarke AR, (2007) A general model of prion strains and their pathogenicity. Science 318: 930-936.
55. Wadsworth JD, Asante EA, Collinge J, (2010) Review: contribution of transgenic models to understanding human prion disease. Neuropathol Appl Neurobiol 36: 576-597.
56. Tanaka M, Chien P, Naber N, Cooke R, Weissman JS, (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428: 323-328.
57. Tanaka M, Chien P, Yonekura K, Weissman JS, (2005) Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121: 49-62.
58. Tanaka M, Collins SR, Toyama BH, Weissman JS, (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442: 585-589.
59. Race R, Chesebro B, (1998) Scrapie infectivity found in resistant species. Nature 392: 770.
60. Race R, Meade-White K, Raines A, Raymond GJ, Caughey B, et al. (2002) Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186 (Suppl 2): S166-170.
61. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B, (2001) Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 75: 10106-10112.
62. Houston EF, Halliday SI, Jeffrey M, Goldmann W, Hunter N, (2002) New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1). J Gen Virol 83: 1247-1250.
63. Jeffrey M, Gonzalez L, Chong A, Foster J, Goldmann W, et al. (2006) Ovine infection with the agents of scrapie (CH1641 isolate) and bovine spongiform encephalopathy: immunochemical similarities can be resolved by immunohistochemistry. J Comp Pathol 134: 17-29.
64. Thorne L, Terry LA, (2008) In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89: 3177-3184.
65. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, et al. (2008) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134: 757-768.
66. Robinson PJ, Pinheiro TJ, (2009) The unfolding of the prion protein sheds light on the mechanisms of prion susceptibility and species barrier. Biochemistry 48: 8551-8558.
67. Gorfe AA, Caflisch A, (2007) Ser170 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier. Faseb J 21: 3279-3287.
68. Christen B, Perez DR, Hornemann S, Wuthrich K, (2008) NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. J Mol Biol 383: 306-312.
69. Priola SA, Chesebro B, (1995) A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 69: 7754-7758.
70. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, et al. (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 94: 10069-10074.
71. Priola SA, Chabry J, Chan K, (2001) Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol 75: 4673-4680.
72. Vorberg I, Groschup MH, Pfaff E, Priola SA, (2003) Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 77: 2003-2009.
73. Goldmann W, Hunter N, Foster JD, Salbaum JM, Beyreuther K, et al. (1990) Two alleles of a neural protein gene linked to scrapie in sheep. Proc Natl Acad Sci U S A 87: 2476-2480.
74. O'Rourke KI, Holyoak GR, Clark WW, Mickelson JR, Wang S, et al. (1997) PrP genotypes and experimental scrapie in orally inoculated Suffolk sheep in the United States. J Gen Virol 78 (Pt 4): 975-978.
75. Finckh U, Muller-Thomsen T, Mann U, Eggers C, Marksteiner J, et al. (2000) High frequency of mutations in four different disease genes in early-onset dementia. Ann N Y Acad Sci 920: 100-106.
76. Revesz T, Holton JL, Lashley T, Plant G, Frangione B, et al. (2009) Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118: 115-130.
77. Goldfarb LG, Brown P, Haltia M, Cathala F, McCombie WR, et al. (1992) Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 31: 274-281.
78. Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, et al. (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133: 3043-3057.
79. Samaia HB, Mari JJ, Vallada HP, Moura RP, Simpson AJ, et al. (1997) A prion-linked psychiatric disorder. Nature 390: 241.
80. Appleby BS, Appleby KK, Hall RC, Wallin MT, (2010) D178N, 129Val and N171S, 129Val genotype in a family with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 30: 424-431.
81. Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB, (1995) Prion protein gene variation among primates. J Mol Biol 245: 362-374.
82. Chandler RL, (1961) Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1: 1378-1379.